Nuveen funds sustainable life sciences project
Nuveen Real Estate will provide a €35 million ($38 million) senior secured loan for the acquisition and construction of One Helix, a cutting-edge life science asset situated in Amsterdam.
One Helix will be developed by a joint venture between Tishman Speyer and Bellco Capital, with the entire 5,155 sq m facility pre-let to Neogene, a biotechnology company specializing in T cell receptor therapies for cancers. Neogene is a subsidiary of AstraZeneca.
The loan is part of Nuveen's pan-European debt strategy, which prioritizes investments in environmentally conscious projects. This marks the strategy's second investment, following a €54 million agreement to finance logistics assets in Berlin for Valor.
One Helix is slated to achieve BREEAM "Outstanding" and will support carbon-negative operations through geothermal heating and cooling systems and rooftop solar panels.